In a matter involving an antitrust counterclaim, a generic pharmaceutical manufacturer alleged that a blockbuster brand manufacturer attempted to monopolize the market and delay entry of the generic product. A CRA expert was retained to analyze market definition, competitive effects, and lost profits damages estimates. The matter settled favorably for our client shortly before trial.
Enhancing antitrust analysis of digital platforms: What can we learn from recent economic research
In this article published in the Summer 2023 issue of Antitrust, the authors review recent economic research on digital platforms and explore the potential...